Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Free Cash Flow (2024 - 2026)

Translational Development Acquisition's Free Cash Flow history spans 3 years, with the latest figure at -$305157.0 for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 31.78% to -$305157.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$681970.0, a 34.59% increase, with the full-year FY2025 number at -$608387.0, up 28.55% from a year prior.
  • Free Cash Flow came in at -$305157.0 for Q1 2026, down from -$117363.0 in the prior quarter.
  • The five-year high for Free Cash Flow was -$88105.0 in Q3 2025, with the low at -$810963.0 in Q4 2024.
  • Historically, Free Cash Flow has averaged -$287417.8 across 3 years, with a median of -$201459.5 in 2025.
  • Biggest five-year swings in Free Cash Flow: soared 85.53% in 2025 and later crashed 31.78% in 2026.
  • Year by year, Free Cash Flow stood at -$810963.0 in 2024, then surged by 85.53% to -$117363.0 in 2025, then crashed by 160.01% to -$305157.0 in 2026.
  • Business Quant data shows Free Cash Flow for TDAC at -$305157.0 in Q1 2026, -$117363.0 in Q4 2025, and -$88105.0 in Q3 2025.